By Martin Matishak
WASHINGTON -- A planned $1.9 billion revamp of the nation's medical countermeasure enterprise was overdue as government scientists were using decades old technology to confront new and emerging biological threats, a senior Obama administration official said here last week (see GSN, Sept. 24).
-snip-
Countermeasures are typically defined as drugs and vaccines that ward against chemical, biological, radiological and nuclear agents and emerging infectious diseases.
-snip-
No comments:
Post a Comment